Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
August 11, 2023 07:00 ET
|
Pyxis Oncology
Third dose cohort initiated in Phase 1 trial of PYX-201, Pyxis Oncology's first ADC product candidate Preliminary data from two Phase 1 trials on track for late 2023 to early 2024 Apexigen...
Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate Updates
August 08, 2023 16:01 ET
|
Iovance Biotherapeutics, Inc.
FDA Priority Review of Biologics License Application (BLA) on Track for Lifileucel in Advanced Melanoma with Prescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023 Preparing for...
IO Biotech Announces Abstract Accepted for Mini Oral Presentation at IASLC 2023 World Conference on Lung Cancer
July 25, 2023 16:05 ET
|
IO Biotech
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology...
Iovance Biotherapeutics to Present Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy at IASLC 2023 World Conference on Lung Cancer
July 25, 2023 16:01 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor...
Non-Small Cell Lung Cancer Market: Segmented: By histology ; By treatment and Region –Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030.
July 24, 2023 14:11 ET
|
ReportLinker
New York, July 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Non-Small Cell Lung Cancer Market: Segmented: By histology ; By treatment and Region –Analysis of...
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committees
May 10, 2023 04:30 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces that...
HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023
April 11, 2023 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., April 11, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today announces that new and updated...
Young Lung Cancer Investigator Awarded a $200,000 Grant to Support Research in Translational Immuno-oncology
April 05, 2023 13:24 ET
|
Lung Cancer Foundation of America
Los Angeles, CA, April 05, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung...
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
March 02, 2023 07:00 ET
|
Prenetics Limited
LONDON and HONG KONG, March 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics...
12.3% CAGR, Circulating Tumor Cells Market to Reflect US$ 9.85 Billion by 2030: Reports Insights
February 27, 2023 06:00 ET
|
REPORTSINSIGHTS CONSULTING PVT LTD
New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The Circulating Tumor Cells (CTC) Market is projected to grow at a CAGR of 12.3% from 2023 to 2030, with a value of USD 9.85 Billion by 2030, according to...